FMS Fresenius Medical Care AG IFRS
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1333141 · Reporting currency EUR
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: EUR | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 5.07B | 4.88B | 4.79B | 4.88B | 5.08B | 4.76B | 4.77B | 4.72B |
| Cost of revenue | 3.68B | 3.64B | 3.58B | 3.70B | 3.81B | 3.61B | 3.60B | 3.55B |
| Gross profit | 1.39B | 1.24B | 1.21B | 1.18B | 1.27B | 1.15B | 1.17B | 1.17B |
| R&D expense | 38.63M | 37.75M | 38.12M | 43.48M | 50.06M | 40.05M | 45.59M | 47.80M |
| SG&A expense | 784.62M | 705.44M | 791.98M | 750.69M | 839.56M | 756.15M | 771.47M | 775.64M |
| Operating income | 593.86M | 476.50M | 425.28M | 331.39M | 258.90M | 462.70M | 424.79M | 246.01M |
| Interest expense | 89.82M | 93.10M | 96.58M | 95.72M | 87.29M | 99.10M | 103.08M | 103.85M |
| Pretax income | 508.46M | 402.57M | 350.55M | 250.65M | 179.12M | 380.53M | 339.46M | 157.83M |
| Income tax | 106.44M | 75.22M | 78.26M | 61.05M | 61.00M | 116.53M | 99.01M | 39.51M |
| Net income | 327.08M | 274.80M | 225.27M | 151.22M | 66.90M | 213.03M | 187.03M | 70.96M |
| EBITDA | 954.43M | 834.72M | 787.31M | 713.99M | 650.84M | 834.79M | 808.55M | 633.75M |
| EPS (basic) | — | 0.94 | 0.77 | 0.52 | — | 0.73 | 0.64 | 0.24 |
| EPS (diluted) | — | 0.94 | 0.77 | 0.52 | — | 0.73 | 0.64 | 0.24 |
| Banking | ||||||||
| Net interest income | -85.39M | -73.94M | -74.73M | -80.74M | -79.78M | -82.17M | -85.33M | -88.19M |
| Balance sheet | ||||||||
| Cash & equivalents | 1.60B | 1.26B | 1.72B | 1.07B | 1.18B | 1.37B | 1.09B | 1.15B |
| Inventory | 2.14B | 2.09B | 2.00B | 2.08B | 2.07B | 2.10B | 2.23B | 2.22B |
| Current assets | 7.90B | 7.82B | 8.14B | 7.96B | 7.92B | 8.09B | 8.69B | 9.28B |
| PP&E, netmay include right-of-use assets (IFRS) | 3.49B | 3.26B | 3.29B | 3.51B | 3.65B | 3.51B | 3.65B | 3.67B |
| Goodwill | 13.57B | 13.59B | 13.62B | 14.64B | 15.17B | 14.23B | 14.81B | 14.68B |
| Intangibles | 1.25B | 1.25B | 1.25B | 1.33B | 1.37B | 1.31B | 1.35B | 1.36B |
| Total assets | 31.00B | 30.89B | 31.29B | 32.74B | 33.57B | 32.51B | 33.90B | 34.34B |
| Current liabilities | 6.25B | 5.76B | 5.66B | 5.45B | 5.66B | 5.89B | 5.94B | 6.20B |
| Short-term debt | 1.60B | 475.76M | 989.83M | 590.56M | 575.28M | 942.87M | 480.83M | 795.73M |
| Long-term debt | 5.69B | 6.32B | 6.33B | 6.15B | 6.26B | 6.23B | 6.85B | 7.02B |
| Total debt | 7.29B | 6.80B | 7.32B | 6.74B | 6.84B | 7.18B | 7.33B | 7.81B |
| Total liabilities | 16.72B | 16.98B | 16.96B | 17.23B | 17.80B | 17.72B | 18.71B | 19.20B |
| Shareholders' equity | 13.31B | 12.95B | 13.27B | 14.37B | 14.58B | 13.62B | 13.93B | 13.91B |
| Net debt | 5.69B | 5.54B | 5.60B | 5.67B | 5.66B | 5.81B | 6.24B | 6.66B |
| Shares outstanding | 279.29M | 289.85M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M |
| Cash flow statement | ||||||||
| Operating cash flow | 1.00B | 741.56M | 774.93M | 162.82M | 831.70M | 984.71M | 442.42M | 127.31M |
| Investing cash flow | -418.23M | -54.01M | -142.05M | -108.24M | -119.19M | -219.93M | 322.55M | -68.37M |
| Financing cash flow | -208.39M | -1.14B | 79.22M | -138.79M | -965.18M | -477.08M | -837.37M | -289.66M |
| Depreciation & amortization | 360.57M | 358.21M | 362.03M | 382.60M | 391.95M | 372.09M | 383.76M | 387.74M |
| Dividends paid | 0 | 0 | — | — | 0 | 0 | — | — |
| Share buybacks | 434.17M | — | — | — | — | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 71 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.